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J. H. MILSTONE
For a long time, it was accepted that calcium and cephalin activate pro-
thrombin. There were secondary questions about the identity of the phos-
phatide and whether it was important that the phosphatide be bound to
protein. Otherwise the issue was closed. Now the basic premise is in
sufficient doubt to warrant a restatement of the problem in the light of
newer observations.
" . . . I have come upon a fact which is of the very highest importance
not only for the question of the coagulation of the blood but for the very
much greater question of the nature of the chemical processes in protoplasm,
which constitute life. This fact is that lecithin, a body omnipresent in
protoplasm, can bring about coagulation." So wrote Wooldridge, in 1883.'
The material he thus caused to coagulate was specially treated plasma from
dogs injected with peptone. The plasma of peptonized dogs was also used
by Howell'0 to assay the coagulant activity of his cephalin preparations. At
that time, Howell employed one of Nolf's terms and wrote of "thrombo-
plastic substances" as "the extractible substance or substances in the tissues
which facilitates the process of clotting." This is considerably more general
than his previous description' of "thromboplastic substance or thromboplas-
tin, which neutralizes the antithrombin... ." Then, and ever since, "throm-
boplastin" has been a rather broad and variable term. It is now applied to
diverse materials from fixed tissue or blood which accelerate coagulation,
especially those which accelerate production of thrombin.
As discussed by Howell, a confusing set of reports had accumulated by 1912. One
group of investigators dealt with heat-stable thromboplastins found in alcohol or ether
extracts, while others used heat-labile, water-soluble preparations. Among the latter
were Morawitz' and Mellanby,1' who designated their aqueous extracts thrombokinase;
and it was clear that they considered thrombokinase to be a direct activator of
prothrombin.
If these old definitions are accepted, it may be considered that a thrombokinase would
activate pure prothrombin, aided only, if at all, by calcium. In this sense, a throm-
bokinase is a specific kind of thromboplastin. There may be other thromboplastins
which would not activate pure prothrombin.
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Howell preferred to consider that, basically, there was only one type of thromboplas-
tin. He proposed that the heat-labile material was merely the thromboplastic lipid in
combination with protein. However, Rumpf'3 believed that the two had distinct effects.
Whereas the aqueous extracts were usually much more active than the lipoid extracts,
the latter were reported to be more effective in the clotting of lipid-poor plasma. To
this, an incomplete answer was offered by the assumption that the lipid was more
effective when combined with protein. Today it is still frequently stated that prothrom-
bin is activated by a lipoprotein.
In the years 1916-17, it was reported by Dale and Walpole,' by Douglas and Cole-
brook,3 and by Heard' that trypsin accelerated blood coagulation. But the time was
not ripe, and this remarkable finding was lost in the shadow of lipoid thromboplastin
for two decades. The isolation of trypsin as a crystalline protein (not a lipoprotein!)
by Kunitz and Northrop`5 offered a finer means for investigation. Promptly, Eagle
and Harris' found that crystalline trypsin activated their crude prothrombin. Conver-
sion to thrombin had also been accelerated by cephalin, with a similar crude pro-
thrombin.'
Thus, Eagle5 was confronted with a dilemma much like that faced by Howell twenty-
five years previously. There were now two sharply distinct classes of thromboplastins:
one represented by a crude ether-soluble cephalin derived from brain; one represented
by crystalline trypsin. Which, if either, was a true thrombokinase? Eagle favored
trypsin and was puzzled by cephalin.
Whereas trypsin is known to activate proenzymes, no lipid is known to do so. There-
fore, it is more attractive to consider that trypsin is a direct activator of prothrombin,
and that the thrombokinases found in blood and tissue preparations may be somewhat
similar enzymes. As logical as this may seem, it has not been widely accepted. The
principal arguments against this idea will be analyzed later in this paper.
Recently, Ferguson7 has discussed the results of his detailed studies and added some
experiments performed with Folch's subfractions of crude brain cephalin. These leave
open the possibility that true cephalin is a potent thromboplastin, as Howell believed.
To date, no clarification of the problem has been achieved by the purification of brain
lipids, other than the separation of anticoagulants.
In contrast, as prothrombin is purified, it reaches a state where it is readily activated
by trypsin, but not by crude cephalin. A purification program which has been in
progress many years has offered repeated opportunities to elaborate on this finding.
The thromboplastin studied
The lipoid thromboplastin studied was similar to that used by Eagle4 as
crude cephalin. It represented that fraction of brain which was soluble in
ether but not in acetone. As such, it contained, among other things, both
cephalin and lecithin. Possibly there are diverse lipids and lipoproteins with
distinct thromboplastic effects; and these thromboplastins may be accom-
panied by inhibitors. It is proposed to neglect these complexities tempo-
rarily and to focus on the main issue: Is this thromboplastin a direct activa-
tor of prothrombin? If not, then what else could be a direct activator? And
how can one account for the undoubted acceleration caused by the lipid?
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It should be mentioned, however, that this thromboplastin is different
from the brain thromboplastin commonly used in clinical tests. Findings in
this laboratory tend to corroborate those of Lewis and Ferguson"8 who re-
ported that the first aqueous extract of acetone-dried brain contains protein
factors of significance in coagulation. Leathes and Mellanby'6 had previously
shown that an aqueous brain extract contained what they considered to be
a kinase, precipitable at pH 5.5 and not soluble in ether. They further in-
dicated'7 that the kinasic action was probably fortified by the presence of
brain lipid.
In short, there is strong indication that an aqueous suspension of brain
contains a thromboplastic factor in addition to the ether-soluble lipoid
thromboplastin as used in this work.
It has occasionally been reported that lipid also augments thrombin activ-
ity. This raises the question whether the acceleration of thrombin produc-
tion is spurious, due merely to a shift in the thrombin assays caused by the
lipid. Results in this laboratory have agreed with the general experience
that the thrombin is actually produced more rapidly, and that the effect is
greater than could be accounted for on the basis of the observed shift in
thrombin assays.
Preparation of the thromboplastin. The following is an outline of the most recent
preparation: 150 gm. fresh calf brain was washed, minced, and triturated in a mortar
for 10minutes with 150 ml. acetone (analytical reagent). The acetone was decanted and
trituration repeated successively with 5 more 150 ml. portions of acetone. The residue
was suspended in 750 ml. ether (u.s.p.) and allowed to stand overnight. The ether
extract was filtered and evaporated under vacuum at 350C. The residue was twice
extracted with 450 ml. portions of acetone for 15 minutes and finally dissolved in 100
ml. ether. This solution was evaporated under vacuum at room temperature and kept
under suction for several hours to approach complete removal of the ether. The yellow
residue, weighing 3.75 gm., was triturated with 37.5 ml. veronal-buffered saline, and
the mixture was centrifuged, yielding a milky suspension which was stored frozen.
Lipid anid prothromitbin
It was observed repeatedly that the apparent activation of crude pro-
thrombin by lipoid thromboplastin plus calcium depended upon the presence
of contaminating material in the prothrombin. If the contaminating material
was destroyed or removed, the prothrombin would lose its responsiveness
to the lipid. Responsiveness to lipid could be restored by adding an appro-
priate protein fraction from plasma.
At the time these investigations were begun, the best available method
for purifying prothrombin was that of Mellanby.'2 In this, the prothrombin
was precipitated with the euglobulins, then extracted from the precipitate
677YALE JOURNAL OF BIOLOGY AND MEDICINE
with very dilute calcium bicarbonate. With modifications,' batches of 39
liters could be prepared at one time on a routine basis.
The calcium bicarbonate extracts were studied extensively. Fresh ex-
tracts were promptly converted to thrombin following addition of lipoid
thromboplastin and calcium chloride. However, aged extracts were not
activated by lipid plus calcium, although they were still activated by an
aqueous extract of lung, as noted in 1938 (unpublished). Later the same
year, Seegers et al.81 reported that their prothrombin was activated promptly
by lung extract but very slowly by cephalin.
The significant material contaminating the prothrombin could be de-
stroyed or removed not only by aging, but also by heating or by adsorption
of the prothrombin on magnesium hydroxide followed by thorough washing.
Figure IA, a 1939 experiment, shows that although the lipid did not activate
heated prothrombin, it accelerated activation in the presence of prothrom-
bin-poor plasma globulin. Figure 1B portrays a 1947 experiment. Here,
the reagents had been prepared in a manner quite different from that of
earlier years, as described elsewhere.2' For reasons discussed at that time,
the prothrombin-poor plasma globulin has been called prothrombokinase.
In Figure 1B the pattern of results is the same; however, the apparent acti-
vation by lipid and calcium was not eliminated as completely as before.
It is apparent that the thromboplastic activity of the lipid depended upon
at least one impurity in the prothrombin, which could be removed and re-
stored at will. Moreover, the prothrombin plus its impurities produced
thrombin without the added lipid, showing that the direct activator of pro-
thrombin was present in, or obtainable from, the blood derivatives. This
suggested that any effect the lipid had on production of thrombin was either
indirect or secondary. For example, it might be considered that the lipid
activated prothrombokinase and thus indirectly hastened activation of pro-
thronmbin.
Lipid and prothromnbokinasc
Collingwood and MacMahon1 wrote of prothrombokinase in 1912, and
proposed that it was converted to thrombokinase in the first step of a three-
stage clotting mechanism. 1. Prothrombokinase -* Thrombokinase; 2. Pro-
thrombin -* Thrombin; 3. Fibrinogen -- Fibrin. Recently, the stages they
postulated have been separated and used for a three-stage analysis.2' In this,
calcium is added to crude prothrombokinase and the mixture is assayed for
thrombokinase activity at successive intervals. This technique makes it
possible to chart the conversion process and, further, to enquire whether
lipoid thromboplastin activates prothrombokinase.
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FIG. 1. Activation of prothrombin by prothrombokinase, lipoid thromboplastin, and
calcium. All experiments were performed with calcium chloride present. Prokinase =
prothrombokinase.
lA. For the experiment of May 7, 1939, the prothrombin was prepared by adding
0.9% of sodium chloride to a calcium bicarbonate extract, aging 3 days in the refriger-
ator, and heating in a 600C. water bath for 5 minutes. The prothrombokinase was
prepared from the residue left after extraction with calcium bicarbonate. The fresh
residue was almost completely dissolved in a volume of oxalated saline equal to half
the original volume of plasma, heated to 56°C. to remove fibrinogen, and treated with
21 gm. ammonium sulfate per 100 ml. The resulting precipitate was dissolved in dis-
tilled water equal to one-fourth the volume of original plasma and dialyzed agailist
oxalated saline. Control tests showed no prothrombin in this reagent at the concentra-
tion employed. The concentration of lipid in the activation mixtures represented a
1/120 dilution of 1% stock suspension. The activation procedure was similar to that
described in 1942.22
1B. For the experiment of October 9, 1947, prothrombin and prothrombokinase
reagents were prepared and tested as described in 1948.24 The most rapidly activated
mixture contained 0.8 ml. prothrombin, 0.1 ml. prothrombokinase, 0.1 ml. of a 1/100
dilution of a 10%o stock suspension of lipid and 0.1 ml. 0.0275 M calcium chloride. For
the "prokinase" curve, the mixture was the same, except that 0.1 ml. buffer was sub-
stituted for lipid. For the "lipid" curve, buffer was substituted for prothrombokinase.
For the "lipid x 10" curve, 0.1 ml. of a 1/10 dilution of stock lipid suspension was used,
with no prothrombokinase added.
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Results are shown in Figure 2. After calcium was added to prothrombo-
kinase, there was a latent period, followed by a rapid increase in thrombo-
kinase activity. When lipid was included there was a shorter latent period
and a higher peak of thrombokinase activity. When ten times as much lipid
was used, there was a pronounced elevation of the thrombokinase peak with
relatively little effect on the latent period. Despite a rapid decline, the
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FIG. 2. Effect of lipoid thromboplastin on the prothrombokinase
activation curve. The materials and methods were those previously
described,' except that only one absorption with barium sulfate was
done in the preparation of the prothrombokinase. For the "no lipid
added" curve: 2.0 ml. prothrombokinase plus 0.2 ml. 0.0275 M calcium
chloride. For the "lipid" curve: 1.8 ml. prothrombokinase, 0.2 ml. of
a 1/100 dilution of a 10% suspension of lipid, plus 0.2 ml. calcium
chloride. For the "lipid x 10" curve: 1.8 ml. prothrombokinase, 0.2 ml.
of a 1/10 dilution of lipid, plus 0.2 ml. calcium chloride. As will be
noted, the "no lipid added" mixture had 1.1 times as much prothrombo-
kinase per ml. as the others. Separate experiments in which the pro-
thrombokinase was constant gave the same pattern of results. The
relative thrombokinase values were not reduced to percentage of an
arbitrary standard.
thrombokinase activity remained, for the duration of the experiment, above
that of the mixture with "no lipid added."
If the principal effect of the lipid were simply the direct activation of
prothrombokinase, the curves should have risen from the origin and been
about ten times as steep with the tenfold quantity of lipid. Since an auto-
catalytic mechanism or a chain reaction is involved,' an indirect effect, such
as protection or enhancement of an autocatalytic factor, could account for as
much shortening of the latent period as was observed. The materials were
crude; and the explanation of the results would probably be complex. In
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any case, the results do not encourage the view that the principal effect of the
lipid is the direct activation of prothrombokinase.
Since the three-stage procedure is new and not fully developed, it is desir-
able to emphasize that it is nevertheless capable of detecting the kind of
effect sought, i.e., a drastic shortening of the latent period with relatively
little increase in peak activity. It was originally shown' that crude
thrombokinase has such an effect on the activation of prothrombokinase.
More recently,' a highly active protein fraction, which may represent a
thrombokinase, has been described under the temporary name of "conver-
ter." At high diluttion, the converter briskly accelerates activation of crude
prothrombokinase without greatly elevatilng the activity peak. Such results
make the converter a candidate for the role of prothrombokinase activator.
Such results have not been obtained with lipoid thromboplastin.
Lipid and trypsini
It is now quite clear that thrombokinase can be obtained from slaughter-
house blood, although it may be necessary to convert it from an inactive
state. The behavior of active thrombokinase is compatible with the possi-
bility that it is an enizyme;24 and it has usually been possible to substitute
crystallized trypsin for blood thrombokinase.
The recent prothrombin preparations, as noted elsewhere, are suspected
of containing a trace of thrombokinase or its precursor. Such prothrombins
give a slight, limited response to lipid plus calcium. Beyond this low limnit,
the addition of more lipid does not lead to faster activation (Fig. 1B). In
contrast, the prothrombin is activated with increasing rapidity when increas-
ing amounts of trypsin are used (Fig. 3).
This last relationship must be borne in mind in the interpretation of ex-
periments which purport to demonstrate that trypsin does not activate pro-
thrombin. In Figure 3 it is seen that 0.1 microgram of crystallized trypsin
did not activate the prothrombin reagent, neither did 0.1 ml. of twice-washed
platelets. However, the two added to prothrombin together produced
measurable thrombin. Experiments like this have sometimes been taken
to imply that trypsin cannot activate prothrombin directly, but must act
through the mediation of a blood factor, in this case platelets. That this
conclusion is not necessarily valid is evident from Figure 3, where a tenfold
quantity of trypsin caused activation without added platelets. In these ex-
periments the range of trypsin concentration corresponded to a very slight
degree of proteolytic activity as measured by the method of Kunitz.' As
further illustrated in Figure 3, larger amounts of trypsin are rapidly de-
structive.
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The necessity for testing several concentrations of enzyme was well recog-
nized by Mellanby and Pratt;' therefore their negative results probably
deterred subsequent investigators from pursuing the lead offered by trypsin.
Using two-fold dilutions of pancreatic juice, they showed that dilutions just
beyond the destructive one failed to activate prothrombin. No attempt was
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FIG. 3. Activation of prothrombin by trypsin, with and without platelets.
0.4 ml. buffer, 0.4 ml. prothrombin, 0.1 ml. platelets, 0.1 ml. Ca 0.0275 M.,
and 0.1 ml. trypsin (1/6,000, 1/600 or 1/60). Ca added 15 seconds before
trypsin. Twice-washed rabbit platelets prepared as described.'5 One hundred
and fifty mg. of crystallized trypsin, containing about 60 mg. protein (plus 90
mg. magnesium sulfate) were dissolved, dialyzed against 0.001 m. HCI, and
diluted to 10 ml. The figures on the chart represent the approximate amount
of trypsin protein added to the activation mixtures.
made to determine how much of the destruction was due to chymotrypsin
and how much to trypsin. So, it is not known whether an activating effect
of trypsin should have been expected to dilute out further than the coin-
bined destructive effects of chymotrypsin and trypsin. It is known that their
activated pancreatic juice contained considerable chymotrypsin, since the
average specimen was said to clot milk quite rapidly. Trypsin does not clot
milk, chymotrypsin does. It is conceivable that in their experiments there
was sufficient trypsin to have an effect on prothrombin in conjunction with
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other components of the clotting system. Their conclusion that trypsin re-
leases an active form of thrombokinase may well be correct. But their re-
sults with crude pancreatic juice do not exclude the possibility that trypsin
can also activate prothrombin directly. No one has yet claimed that crystal-
lized trypsin cannot activate prothrombin.
If it is contemplated that prothrombin is ordinarily activated by an
enzyme, it might be considered that the lipid could act as a cofactor. Such
a relation of lecithin to the thrombokinase of daboia venom was considered
by Leathes and Mellanby.'7 So far, attempts in this laboratory to show that
the lipid can act as cofactor for trypsin have not succeeded. Experiments to
be reported' have failed to show that the lipid acts as cofactor for crystal-
lized trypsin in the activation of either crystallized trypsinogen or crystal-
lized chymotrypsinogen. Little can be said about the lipid and the
thrombokinase of blood.
Thus, the mode of action of lipoid thromboplastins remains an unsolved
problem. However, the possibilities have not been exhausted. The heighten-
ing of the thrombokinase curve by the lipid offers one point of departure.
It will be of interest to inquire whether lipid modifies production of
thrombokinase, or certain side-effects, or the activity or persistence of the
kinase. An entire group of possibilities is embraced by Howell's proposals'
that the lipid would have no effect unless an anticoagulant were also present.
Another such mechanism has recently been suggested by Jacox.'
Discussion
If the basic clotting mechanism is represented as three primary reactions:
1. Prothrombokinase - Thrombokinase
2. Prothrombin - Thrombin
3. Fibrinogen -> Fibrin
there are many things left unexplained. Among them is the mode of action
of the lipoid thromboplastins. The foregoing studies on a given type of
lipoid thromboplastin were designed to inquire how it impinged on the above
basic mechanism. A concurrent review of the literature attempted to locate
the origins of certain ideas and the evidence in their favor.
There is no good evidence that lipoid thromboplastin, in the presence of
calcium, will activate either prothrombin or prothrombokinase. Nor is there
proof that the lipid will act as simple cofactor for thrombokinase or for
trypsin.
These views are derived from an extended study involving separation
of the factors and reactions of blood coagulation. As these separationsYALE JOURNAL OF BIOLOGY AND MEDICINE
progress, the problem may assume a different aspect. As one example, re-
moval of impurities from prothrombin preparations has almost eliminated
their susceptibility to activation by lipid, while responsiveness to trypsin
was preserved. It cannot be said that, as further impurities are removed,
the prothrombin preparations will not regain their susceptibility to lipid
and/or lose their responsiveness to trypsin. The facts at hand do not sug-
gest that this will happen. Nevertheless, it is obligatory to emphasize that
the prothrombins studied here have not been pure. Furthermore, a
thoroughly documented pure prothrombin has not been described anywhere.
Additional uncertainties accumulate as consideration is given to the crudity
of lipoid thromboplastins and to the question of lipoid anticoagulants.
As the phosphatide theory has become weaker, there has risen in its place
the belief that lipoproteins may have thromboplastic effects which are quali-
tatively different from those of phosphatides. This is uncertain. The opinion
that lipoproteins activate prothrombin is based on the fact that crude
thromboplastic activity and lipoprotein are often found together and seem to
be altered together by various procedures. However, as here shown the
finding that a material accelerates activation of crude prothrombin does not
constitute proof that it is the direct activator.
In the search for a true thrombokinase, the evidence in favor of lipopro-
teins is as weak as that for phosphatides. One must hesitate to accept a sus-
pension of tissue particulates as a pure substance. Such material undoubtedly
hastens production of thrombin in crude systems. But there has been no
successful attempt to isolate its lipoprotein and to show that its lipoprotein
activates prothrombin. Caution is further indicated with regard to the
notion that the lipoprotein is an enzyme; for there seems to be no estab-
lished example of a lipoprotein which is an enzyme.
Some of these common assumptions may eventually prove correct; but
for the present, they should be recognized as opinions, with some suggestive
support from experiments. Then, they will no longer obscure the more
plausible view that thrombokinase, the activator of prothrombin, is an
enzyme, possibly proteolytic, and quite possibly not a lipoprotein. For this,
there is at least as much suggestive evidence, and the further advantage that
the idea is in harmony with the general findings of biochemistry. Among
the less attractive alternatives, the facts do not exclude a mechanism which
requires the simultaneous presence of two or more biologic activators.
With a few exceptions, most recent investigators have turned aside from
the lead offered by trypsin. This neglect has had its reasons. The work of
Mellanby and Pratt seemed to be devastating and probably discouraged
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many. But their experiments were uncontrolled for complications due to
the chymotrypsin now known to have been present. Consequently their data
do not exclude the possibility that trypsin can activate prothrombin. A
further apparent setback occurred when the weight of evidence" turned
against the view that a fibrinolytic enzyme from blood can function as
thrombokinase. This issue is not entirely settled. More important, there is
no reason to believe that only one proteolytic enzyme is obtainable from
blood. Finally, it has been difficult to demonstrate proteolytic activity where
thrombokinase seemed to be present. But the present experiments show that
only a minute amount of added enzyme, in terms of micrograms or of
proteolytic activity, suffices to produce a large effect on the activation of
prothrombin.
The evidence is not adequate to close the problem; rather it should be
opened wider. Along with the hypotheses proposed in the past, more atten-
tion should be given to the possibility that prothrombin can be activated by
one or more enzymes, and that this basic process can be modified in an in-
direct or secondary manner by phosphatides and by lipoproteins. The rela-
tive importance of lipoid thromboplastins in the physiologic control of the
clotting mechanism is another question.
Summnary
1. In the presence of calcium, either trypsin or crude cephalin seems to
activate crude prothrombin. Which, if either, represents a direct activator
of prothrombin?
2. Prothrombin is a proenzyme. Trypsin activates some proenzymes.
No lipid is known to do so.
3. As prothrombin is purified, it reaches a state where it is readily acti-
vated by crystallized trypsin, but not by crude cephalin.
4. In the presence of platelets, one-tenth microgram of trypsin produced
a large effect on conversion of prothrombin. Without added platelets, one
microgram of trypsin readily activated the prothrombin. Thus, enhance-
ment of trypsin effect by other factors does not prove that trypsin would be
ineffective alone, provided the proper quantity was used.
5. The behavior of thrombokinase derived from blood is consistent with
the possibility that it is an enzyme.
6. Lipoid thromboplastin accelerated production of thrombin from a
mixture of prothrombin, prothrombokinase, and calcium.
7. In three-stage tests the lipid raised the peak of the thrombokinase
curve, but caused only minor shortening of the latent period. This does not
encourage the view that the lipid activates the prokinase. In contrast, three-
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stage tests on a recently described protein fraction from blood have en-
couraged the view that it may activate the prokinase.
8. Experiments to be published have failed to show that the lipid acts
as cofactor for crystallized trypsin in the activation of crystallized trypsino-
gen or crystallized chymotrypsinogen.
9. The problem has not been clarified by consideration of crude lipo-
proteins. There is no good evidence that lipoproteins activate prothrombin.
There seems to be no established case of a lipoprotein which is an enzyme.
10. The actions of lipoid thromboplastins remain an unsolved problem.
Several possibilities are yet to be explored.
Conclusion
Along with the hypotheses proposed in the past, more attention should be
given to the possibility that prothrombin can be activated by one or more
enzymes, and that this basic process can be modified in an indirect or
secondary manner by lipids and by lipoproteins.
It is a pleasure for the writer to acknowledge his indebtedness to Dr. Milton C.
Winternitz. The aid and complete freedom offered by Dr. Winternitz made it possible
to resume this work at the end of World War II. His friendly interest and encourage-
ment continuously fostered an enthusiastic attack on the problem.
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